DACRAs are novel therapeutic candidates for the treatment of NAFLD and NASH

被引：0
|
作者：
Nielsen, Mette J. [1 ,2 ]
Hjuler, Sara T. [1 ]
Gydesen, Sofie [1 ]
Karsdal, Morten A. [1 ]
Henriksen, Kim [1 ]
机构：
[1] Nord Biosci AS, Herlev, Denmark
[2] Univ Southern Denmark, Odense Univ Hosp, Dept Gastroenterol & Hepatol, Odense, Denmark
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2178
引用
收藏
页码：1269A / 1269A
页数：1
相关论文
共 50 条
  • [1] Incretin as a Novel Treatment Strategy for NAFLD/NASH
    Takeda, Yasuo
    Ikeda, Ryuji
    Kondo, Tomoko
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2016, 136 (04): : 573 - 577
  • [2] Salidroside in the Treatment of NAFLD/NASH
    Qu, Baozhen
    Liu, Xuemao
    Liang, Yanjiao
    Zheng, Keke
    Zhang, Chunling
    Lu, Linlin
    CHEMISTRY & BIODIVERSITY, 2022, 19 (12)
  • [3] Current medical treatment for NAFLD/NASH
    Masrour, Oumnia
    Bardou-Jacquet, Edouard
    NUTRITION CLINIQUE ET METABOLISME, 2023, 37 (02): : 72 - 76
  • [4] Letter to the Editor: Saroglitazar for Treatment of NAFLD and NASH
    Kumar, Karan
    Kulkarni, Anand
    Jagdish, Rakesh Kumar
    HEPATOLOGY, 2021, 74 (06) : 3559 - 3560
  • [5] NAFLD/NASH
    Bugianesi, Elisabetta
    Petta, Salvatore
    JOURNAL OF HEPATOLOGY, 2022, 77 (02) : 549 - 550
  • [6] Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
    Xu, Gao-Xin
    Wei, Song
    Yu, Chao
    Zhao, Si-Qi
    Yang, Wei-Jun
    Feng, Yong-Heng
    Pan, Chao
    Yang, Kun-Xing
    Ma, Yong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [7] Role and effective therapeutic target of gut microbiota in NAFLD/NASH
    Liu, Qun
    Liu, Shousheng
    Chen, Lizhen
    Zhao, Zhenzhen
    Du, Shuixian
    Dong, Quanjiang
    Xin, Yongning
    Xuan, Shiying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (03) : 1935 - 1944
  • [8] HTD1801 A NOVEL TREATMENT ADDRESSING THE UNDERLYING METABOLIC FEATURES OF NAFLD/NASH
    Liu, Liping
    Bai, Ru
    Yu, Li
    Yu, Meng
    Fu, Xinxiang
    HEPATOLOGY, 2019, 70 : 47A - 47A
  • [9] HTD1801 A NOVEL TREATMENT FOR NAFLD/NASH AND PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Liu, Liping
    Bai, Ru
    Yu, Li
    Yu, Meng
    Fu, Xinxiang
    HEPATOLOGY, 2019, 70 : 1261A - 1262A
  • [10] Ammonia: A novel target for the prevention of NAFLD progression in NASH
    De Chiara, F.
    Thomsen, K. L.
    Habtesion, A.
    Davies, N.
    Hall, A.
    Rombouts, K.
    Andreola, F.
    Jones, H.
    Mookerjee, R.
    Jalan, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S359 - S360
12345